Through Immunohistochemistry (IHC) analysis, we confirmed that the proliferation marker, Ki67, was remarkably downregulated (a 2.3-fold decrease compared to the control) in the tumor tissues administered with compound 10 (Figure 6G, right panel). The gene discussed is MKI67; the disease is neoplasm.